A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive ...
Aug 10, 2018
0
478
A new era in the management of glaucoma is ushered in by a landmark study published in the Journal of Glaucoma, official journal of the World Glaucoma Association. Patients with primary open angle glaucoma (POAG) showed significant ...
Nov 6, 2018
0
7
Scientists have discovered new genetic areas linked to an increased risk of glaucoma - the leading cause of irreversible blindness worldwide.
Apr 5, 2016
0
117
A type of glaucoma called normal-tension glaucoma is associated with an increased risk of cognitive impairment and possibly dementia, finds research published online in the British Journal of Ophthalmology.
Mar 29, 2021
0
47
A 12-year-old Duke University spinoff founded by two Duke professors has received regulatory approval for its first drug: once-a-day eye drops for glaucoma patients.
Jan 3, 2018
0
8
(HealthDay)—Oral systemic agomelatine has a hypotensive effect that decreases intraocular pressure (IOP) in both eyes of treatment-resistant primary open angle glaucoma (POAG) patients, according to a study published in ...
Apr 10, 2015
0
13
A Northwestern Medicine study in mice has identified new treatment targets for glaucoma, including preventing a severe pediatric form of glaucoma, as well as uncovering a possible new class of therapy for the most common ...
Oct 18, 2021
0
107
New study suggests that less than a fifth of shoppers were aware of the need for tests of the pressure inside their eyes (intraocular pressure), when measured at a Pop-Up health check station set up across eight shopping ...
Nov 27, 2019
0
2
(HealthDay) -- An ocular stent that's designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the U.S. Food and Drug Administration.
Jun 26, 2012
0
0
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over ...
Jan 7, 2021
0
121
